AUM BioTech
AUM Biotech is a biotechnology company that provides advanced gene silencing tools based on antisense oligonucleotide (ASO) technology. Their proprietary AUMsilence platform utilizes next-generation chemical modifications and AI-driven design for enhanced stability, activity, and precision in gene silencing. A key differentiator is their self-delivering sdASO™ reagents, which eliminate the need for transfection reagents, viral vectors, or electroporation, simplifying protocols and reducing cellular toxicity. AUM Biotech's products are versatile, working across a wide range of cell types, including difficult-to-transfect primary cells and in vivo models. Their offerings include specialized ASOs for mRNA knockdown (AUMsilence™), microRNA inhibition (AUMantagomir™), long non-coding RNA knockdown (AUMlnc™), blocker oligos (AUMblock™), exon skipping (AUMskip™), and viral RNA silencing (AUMsilence V+™). They also offer a budget-friendly, transfection-optimized line (toASO™) including AUMsaver™ for high-throughput screening and routine lab work. The company's technology is validated in numerous high-impact publications and applied in research areas such as cancer therapy, neurodegenerative diseases, and viral infections.
AUM BioTech
AUM Biotech is a biotechnology company that provides advanced gene silencing tools based on antisense oligonucleotide (ASO) technology. Their proprietary AUMsilence platform utilizes next-generation chemical modifications and AI-driven design for enhanced stability, activity, and precision in gene silencing. A key differentiator is their self-delivering sdASO™ reagents, which eliminate the need for transfection reagents, viral vectors, or electroporation, simplifying protocols and reducing cellular toxicity. AUM Biotech's products are versatile, working across a wide range of cell types, including difficult-to-transfect primary cells and in vivo models. Their offerings include specialized ASOs for mRNA knockdown (AUMsilence™), microRNA inhibition (AUMantagomir™), long non-coding RNA knockdown (AUMlnc™), blocker oligos (AUMblock™), exon skipping (AUMskip™), and viral RNA silencing (AUMsilence V+™). They also offer a budget-friendly, transfection-optimized line (toASO™) including AUMsaver™ for high-throughput screening and routine lab work. The company's technology is validated in numerous high-impact publications and applied in research areas such as cancer therapy, neurodegenerative diseases, and viral infections.